Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Free Research Report on Novo-Nordisk A/S, Nucor Corp., WellPoint, Inc., Cooper Companies, Inc. (The) and Vertex Pharmaceuticals Inc.

COO, NVO, NUE, ELV
Free Research Report on Novo-Nordisk A/S, Nucor Corp., WellPoint, Inc., Cooper Companies, Inc. (The) and Vertex Pharmaceuticals Inc.
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=986448&ProfileId=051205&sourceType=1

NEW YORK, NY -- (Marketwire) -- 02/15/13 -- Today, Traders Insight announced new research reports highlighting Novo-Nordisk A/S (NYSE: NVO), Nucor Corp. (NYSE: NUE), WellPoint, Inc. (NYSE: WLP), Cooper Companies, Inc. (The) (NYSE: COO) and Vertex Pharmaceuticals Inc. Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Novo-Nordisk A/S Research Report
Novo Nordisk A/S is a Denmark-based company engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company reports two business segments: Diabetes care and Biopharmaceuticals. The Diabetes care division offers a range of diabetes products, including insulin pens and needles, such as FlexPen, NovoPen and FlexTouch, among others, and diabetes medicine, such as insulin- and non-insulin treatment, among others. The Full Research Report on Novo-Nordisk A/S - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [www.TradersInsight.net/r/2013-02-07/34c4_NVO]

Nucor Corp. Research Report
Nucor Corporation and its affiliates (Nucor) manufactures steel and steel products. The Company also produces direct reduced iron (DRI) for use in its steel mills. Through The David J. Joseph Company and its affiliates (DJJ) the Company also processes ferrous and nonferrous metals and brokers ferrous and nonferrous metals, pig iron, hot briquetted iron (HBI) and DRI. The Full Research Report on Nucor Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [www.TradersInsight.net/r/2013-02-07/4210_NUE]

WellPoint, Inc. Research Report
WellPoint, Inc. (WellPoint) is a health benefit company in terms of medical membership in the United States, serving 34.3 million medical members through its affiliated health plans and a total of 65.3 million individuals through all subsidiaries as of December 31, 2011. The Company manages its operations through three segments: Commercial, Consumer, and Other. The Full Research Report on WellPoint, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [www.TradersInsight.net/r/2013-02-07/1f8d_WLP]

Cooper Companies, Inc. (The) Research Report
The Cooper Companies, Inc. (Cooper) is a global medical products company that serves the specialty healthcare market through its two business units, CooperVision, Inc. (CVI) and CooperSurgical, Inc. (CSI). CVI develops, manufactures and markets a range of contact lenses for the global vision correction market. CVI specializes in lenses for astigmatism, presbyopia and ocular dryness. The Full Research Report on Cooper Companies, Inc. (The) - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [www.TradersInsight.net/r/2013-02-07/df9c_COO]

Vertex Pharmaceuticals Inc. Research Report
Vertex Pharmaceuticals Incorporated (Vertex) is in the business of discovering, developing, manufacturing and commercializing small molecule drugs for the treatment of serious diseases. The Full Research Report on Vertex Pharmaceuticals Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [www.TradersInsight.net/r/2013-02-07/0c25]

About Traders Insight
Our model of enabling open collaboration between members is breaking new ground into the investment community. By tapping into the resources of the community, we are crowd-sourcing our reach. As a result -- we have been able to identify some of the greatest moving companies on the market today. The evidence is in the results, join today and experience what you've been missing.

Press Contact:

Cora S. Patton
press@TradersInsight.net



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today